Ann Marie is a dual MD/MBA candidate at Duke University with a passion for leveraging clinical insight to drive innovation in healthcare. She earned her Bachelor of Science in Biology from the University of Tulsa before conducting cancer research at UT Southwestern Medical Center. Prior to medical school, she worked as a venture capital associate at the Oklahoma Life Science Fund, where she evaluated and supported early-stage life science startups. Her cross-disciplinary background in research, business, and medicine gives her a systems-level perspective on both the challenges and opportunities in healthcare. Ann Marie is deeply committed to expanding access to and the affordability of care, and she aspires to bridge medicine and business as a physician-innovator by turning bold ideas into tangible, meaningful impact for the patients who need them most.

‍

What is a healthcare advancement you hope to see in your lifetime?

I hope to see advancements in early disease detection‚ affordable cancer diagnostics, AI-powered imaging, and wearable sensors capable of identifying subtle physiologic changes. Detecting diseases like cancer or Alzheimer's at their earliest stages could dramatically improve survival, reduce treatment costs, and lessen the overall burden of disease.

‍

What excites you most about working with ARTIS?

Being at the center of groundbreaking healthcare innovations and working alongside founders tackling the field's most pressing challenges. The opportunity to help shape solutions that could transform countless patients' lives is both inspiring and deeply motivating.

‍

What is your greatest accomplishment?

One of my greatest accomplishments was being invited to attend the Nobel Laureate Award Ceremony in 2023. Being surrounded by some of the brightest minds in the world was a reminder of how I should always strive in my own work to be a force for positive change, both in healthcare and beyond.